Your browser doesn't support javascript.
loading
Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients.
Jan, Muhammad Y; Sayegh, Skye E; Webb, Hanna T; Adebiyi, Oluwafisayo; Anderson, Melissa D; Mishler, Dennis P; Yaqub, Muhammad S; Taber, Tim; Sharfuddin, Asif A.
Afiliação
  • Jan MY; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Sayegh SE; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Webb HT; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Adebiyi O; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Anderson MD; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Mishler DP; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Yaqub MS; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Taber T; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Sharfuddin AA; Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Kidney Int Rep ; 6(9): 2468-2471, 2021 Sep.
Article em En | MEDLINE | ID: mdl-34222731
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article